Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators
- PMID: 2548857
- PMCID: PMC401028
- DOI: 10.1002/j.1460-2075.1989.tb03576.x
Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators
Abstract
The Epstein-Barr virus (EBV) genome codes for several transcriptional trans-activators. One of them, the BZLF1 open reading frame (ORF)-encoded product EB1, is able to induce the productive cycle in infected B cells. From the cloning and characterization of full-length cDNAs, we found that EB1 could be made from three overlapping messenger RNAs expressed under the control of two different promoters that we call P1 and P2. The first mRNA, 1 kb long, is made from the P1 promoter and codes for EB1 alone. The two other mRNAs, respectively 3 and 4 kb long and made by facultative splicing, are bicistronic mRNAs. They code not only for the trans-activator EB1 but also for a second EBV transcriptional trans-activator R, encoded by the BRLF1 ORF. In effect, authentic EB1 and R proteins are expressed from the 3 and 4 kb long cDNAs as demonstrated by identification of the proteins with specific antisera. In addition, EB1 and R expressed from the 3 and 4 kb cDNAs activate transcription from their specific targets in the EBV early promoter DR.
Similar articles
-
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.J Virol. 1989 Dec;63(12):5276-84. doi: 10.1128/JVI.63.12.5276-5284.1989. J Virol. 1989. PMID: 2555554 Free PMC article.
-
Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.J Gen Virol. 1996 Mar;77 ( Pt 3):501-9. doi: 10.1099/0022-1317-77-3-501. J Gen Virol. 1996. PMID: 8601788
-
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.EMBO J. 1986 Dec 1;5(12):3243-9. doi: 10.1002/j.1460-2075.1986.tb04635.x. EMBO J. 1986. PMID: 3028777 Free PMC article.
-
Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.J Gen Virol. 2000 Jul;81(Pt 7):1791-9. doi: 10.1099/0022-1317-81-7-1791. J Gen Virol. 2000. PMID: 10859385
-
The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.J Virol. 1989 Feb;63(2):615-23. doi: 10.1128/JVI.63.2.615-623.1989. J Virol. 1989. PMID: 2536097 Free PMC article.
Cited by
-
In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein.J Virol. 1990 Jun;64(6):2560-8. doi: 10.1128/JVI.64.6.2560-2568.1990. J Virol. 1990. PMID: 2159531 Free PMC article.
-
The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.J Virol. 1990 Aug;64(8):3753-9. doi: 10.1128/JVI.64.8.3753-3759.1990. J Virol. 1990. PMID: 2164595 Free PMC article.
-
Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.J Virol. 1999 Dec;73(12):9858-66. doi: 10.1128/JVI.73.12.9858-9866.1999. J Virol. 1999. PMID: 10559298 Free PMC article.
-
Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.J Virol. 2002 Apr;76(8):4113-8. doi: 10.1128/jvi.76.8.4113-4118.2002. J Virol. 2002. PMID: 11907252 Free PMC article.
-
Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.PLoS One. 2008 Feb 6;3(2):e1569. doi: 10.1371/journal.pone.0001569. PLoS One. 2008. PMID: 18253508 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous